{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:44:37Z","timestamp":1791243877036,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"DOI":"10.1245\/s10434-026-20637-w","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:59:51Z","timestamp":1790881191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Universal versus Guideline-Directed Germline Testing in Breast Cancer: Incremental Diagnostic Yield in a Predominantly Black Population"],"prefix":"10.1245","author":[{"given":"K.","family":"Velazquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Roudakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Alberty-Oller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"4","key":"20637_CR1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.rcl.2023.12.014","volume":"62","author":"MM Patel","year":"2024","unstructured":"Patel MM, Adrada BE. Hereditary Breast Cancer: BRCA mutations and beyond. Radiol Clin North Am. 2024;62(4):627\u201342. https:\/\/doi.org\/10.1016\/j.rcl.2023.12.014.","journal-title":"Radiol Clin North Am"},{"issue":"2","key":"20637_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-023-07137-1","volume":"203","author":"L Westbrook","year":"2024","unstructured":"Westbrook L, Miltenburg D, Souter V, et al. Hereditary cancer testing in a diverse sample across three breast imaging centers. Breast Cancer Res Treat. 2024;203(2):365\u201372. https:\/\/doi.org\/10.1007\/s10549-023-07137-1.","journal-title":"Breast Cancer Res Treat"},{"key":"20637_CR3","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1245\/s10434-016-5328-7","volume":"23","author":"A Chiba","year":"2016","unstructured":"Chiba A, Hoskin TL, Hallberg EJ, et al. Impact that timing of genetic mutation diagnosis has on surgical decision-making and outcome for BRCA1\/BRCA2 mutation carriers with breast cancer. Ann Surg Oncol. 2016;23:3232\u20138. https:\/\/doi.org\/10.1245\/s10434-016-5328-7.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"20637_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/gim.2017.231","volume":"20","author":"HW Tuffaha","year":"2018","unstructured":"Tuffaha HW, Mitchell A, Ward RL, et al. Cost-effectiveness analysis of germline BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genet Med. 2018;20(9):985\u201394. https:\/\/doi.org\/10.1038\/gim.2017.231.","journal-title":"Genet Med."},{"issue":"2","key":"20637_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10549-024-07283-0","volume":"206","author":"H Assad","year":"2024","unstructured":"Assad H, Levitin M, Petrucelli N, et al. Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1\/2 variants evaluated at a large urban comprehensive cancer center. Breast Cancer Res Treat. 2024;206(2):261\u201372. https:\/\/doi.org\/10.1007\/s10549-024-07283-0.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"20637_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.6004\/jnccn.2026.0007","volume":"24","author":"HH Cheng","year":"2026","unstructured":"Cheng HH, Giri VN, Goggins M, et al. Genetic\/familial high-risk assessment: breast, ovarian, pancreatic, and prostate, version 3.2026. NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Ntw. 2026;24(2):2\u201310.","journal-title":"J Natl Compr Cancer Ntw"},{"issue":"1","key":"20637_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1245\/s10434-020-09123-z","volume":"28","author":"JJ Alberty-Oller","year":"2021","unstructured":"Alberty-Oller JJ, Weltz S, Santos A, et al. Adherence to NCCN Guidelines for genetic testing in breast cancer patients: who are we missing? Ann Surg Oncol. 2021;28(1):281\u20136. https:\/\/doi.org\/10.1245\/s10434-020-09123-z.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"20637_CR8","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.1245\/s10434-025-17820-w","volume":"32","author":"D Brabender","year":"2025","unstructured":"Brabender D, Siegel E, Culver JO, et al. Identification of patients at elevated cancer risk through a community-based genetic testing program. Ann Surg Oncol. 2025;32(12):9041\u20139. https:\/\/doi.org\/10.1245\/s10434-025-17820-w.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"20637_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.6004\/jadpro.2021.12.7.3","volume":"12","author":"M Ward","year":"2021","unstructured":"Ward M, Elder B, Habtemariam M. Current testing guidelines: a retrospective analysis of a community-based hereditary cancer program. J Adv Pract Oncol. 2021;12(7):693\u2013701. https:\/\/doi.org\/10.6004\/jadpro.2021.12.7.3.","journal-title":"J Adv Pract Oncol."},{"issue":"1","key":"20637_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13073-023-01174-7","volume":"15","author":"ND Rao","year":"2023","unstructured":"Rao ND, Kaganovsky J, Malouf EA, et al. Diagnostic yield of genetic screening in a diverse, community-ascertained cohort. Genome Med. 2023;15(1):26. https:\/\/doi.org\/10.1186\/s13073-023-01174-7.","journal-title":"Genome Med."},{"issue":"3","key":"20637_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jmedgenet-2022-108519","volume":"60","author":"JM Tiller","year":"2023","unstructured":"Tiller JM, Cousens NE, Kaur R, et al. Population-based BRCA1\/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study. J Med Genet. 2023;60(3):265\u201373. https:\/\/doi.org\/10.1136\/jmedgenet-2022-108519.","journal-title":"J Med Genet"},{"key":"20637_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bpobgyn.2020.02.007","volume":"65","author":"O Evans","year":"2020","unstructured":"Evans O, Gaba F, Manchanda R. Population-based genetic testing for Women\u2019s cancer prevention. Best Pract Res Clinical Obstet Gynaecol. 2020;65:139\u201353. https:\/\/doi.org\/10.1016\/j.bpobgyn.2020.02.007.","journal-title":"Best Pract Res Clinical Obstet Gynaecol"},{"issue":"6","key":"20637_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/gim.2016.175","volume":"19","author":"S Liberman","year":"2017","unstructured":"Liberman S, Lahad A, Tomer A, et al. Population screening for BRCA1\/2 mutations: lessons from qualitative analysis of the screening experience. Genet Med. 2017;19(6):628\u201334. https:\/\/doi.org\/10.1038\/gim.2016.175.","journal-title":"Genet Med."},{"issue":"37","key":"20637_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.18.01631","volume":"2019","author":"PD Beitsch","year":"2019","unstructured":"Beitsch PD, Whitworth PW, Hughes K, et al. Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol. 2019;2019(37):453\u201360. https:\/\/doi.org\/10.1200\/JCO.18.01631.","journal-title":"J Clin Oncol."},{"issue":"4","key":"20637_CR15","doi-asserted-by":"publisher","first-page":"e37428","DOI":"10.7759\/cureus.37428","volume":"15","author":"JC Jones","year":"2023","unstructured":"Jones JC, Golafshar MA, Coston TW, et al. Universal genetic testing vs. guideline-directed testing for hereditary cancer syndromes among traditionally underrepresented patients in a community oncology program. Cureus. 2023;15(4):e37428. https:\/\/doi.org\/10.7759\/cureus.37428.","journal-title":"Cureus."},{"issue":"9","key":"20637_CR16","doi-asserted-by":"publisher","first-page":"e2431427","DOI":"10.1001\/jamanetworkopen.2024.31427","volume":"7","author":"JF Boileau","year":"2024","unstructured":"Boileau JF, Prakash I, Basik M, et al. Universal genetic testing for newly diagnosed invasive breast cancer. JAMA Netw Open. 2024;7(9):e2431427. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.31427.","journal-title":"JAMA Netw Open"},{"issue":"26","key":"20637_CR17","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1200\/JCO.2015.64.3809","volume":"2019","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, et al. Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons. Ann Surg Oncol. 2019;2019(26):3025\u201331. https:\/\/doi.org\/10.1200\/JCO.2015.64.3809.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"20637_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1245\/s10434-022-12595-w","volume":"30","author":"JO Culver","year":"2023","unstructured":"Culver JO, Freiberg Y, Ricker C, et al. Integration of universal germline genetic testing for all new breast cancer patients. Ann Surg Oncol. 2023;30(2):1017\u201325. https:\/\/doi.org\/10.1245\/s10434-022-12595-w.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"20637_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamaoncol.2020.6252","volume":"7","author":"NJ Samadder","year":"2021","unstructured":"Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 2021;7(2):230\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6252.","journal-title":"JAMA Oncol."},{"issue":"10","key":"20637_CR20","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/jnci\/djy027","volume":"110","author":"TP Slavin","year":"2018","unstructured":"Slavin TP, Van Tongeren LR, Behrendt CE, et al. Prospective study of cancer genetic variants: Variation in rate of reclassification by ancestry. J Natl Cancer Inst. 2018;110(10):1059\u201366. https:\/\/doi.org\/10.1093\/jnci\/djy027.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"20637_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.JAA.0000873796.81961.da","volume":"35","author":"A DeTroye","year":"2022","unstructured":"DeTroye A, Gabbett K, Yi C, et al. Genetic testing for patients at risk of hereditary breast and ovarian cancer. JAAPA Off J Am Acad Phys Assist. 2022;35(10):48\u201352. https:\/\/doi.org\/10.1097\/01.JAA.0000873796.81961.da.","journal-title":"JAAPA Off J Am Acad Phys Assist"},{"key":"20637_CR22","doi-asserted-by":"publisher","first-page":"107210","DOI":"10.1016\/j.cct.2023.107210","volume":"130","author":"VB Sheppard","year":"2023","unstructured":"Sheppard VB, Sutton AL, Hurtado-de-Mendoza A, et al. Addressing disparities in the uptake of genetic counseling and testing in African American women; rationale, design and methods. Contemporary Clin Trials. 2023;130:107210. https:\/\/doi.org\/10.1016\/j.cct.2023.107210.","journal-title":"Contemporary Clin Trials"},{"issue":"8","key":"20637_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1089\/jwh.2019.7984","volume":"29","author":"AL Sutton","year":"2020","unstructured":"Sutton AL, Hurtado-de-Mendoza A, Quillin J, et al. Reducing disparities in receipt of genetic counseling for underserved women at risk of hereditary breast and ovarian cancer. J Womens Health. 2020;29(8):1131\u20135. https:\/\/doi.org\/10.1089\/jwh.2019.7984.","journal-title":"J Womens Health"},{"issue":"123","key":"20637_CR24","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cncr.30621","volume":"2017","author":"D Cragun","year":"2017","unstructured":"Cragun D, Weidner A, Lewis C, et al. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cancer. 2017;2017(123):2497\u2013505. https:\/\/doi.org\/10.1002\/cncr.30621.","journal-title":"Cancer."},{"issue":"36","key":"20637_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11606-020-06064-x","volume":"2021","author":"E Chapman-Davis","year":"2021","unstructured":"Chapman-Davis E, Zhou ZN, Fields JC, et al. Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian cancer center. J Gen Intern Med. 2021;2021(36):35\u201342. https:\/\/doi.org\/10.1007\/s11606-020-06064-x.","journal-title":"J Gen Intern Med."},{"issue":"9","key":"20637_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/jwh.2021.0113","volume":"31","author":"SO Nnorom","year":"2022","unstructured":"Nnorom SO, Wilson LL. Breast cancer in Black women: racial\/ethnic disparities affecting survival. J Womens Health. 2022;31(9):1255\u201361. https:\/\/doi.org\/10.1089\/jwh.2021.0113.","journal-title":"J Womens Health"},{"issue":"1","key":"20637_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","volume":"27","author":"FM Howard","year":"2021","unstructured":"Howard FM, Olopade OI. Epidemiology of triple-negative breast cancer: a review. Cancer J. 2021;27(1):8\u201316. https:\/\/doi.org\/10.1097\/PPO.0000000000000500.","journal-title":"Cancer J"},{"issue":"3","key":"20637_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clbc.2024.11.024","volume":"25","author":"VA Pleasant","year":"2025","unstructured":"Pleasant VA, Merajver SD. Universal genetic counseling and testing for Black women: a risk-stratified approach to addressing breast cancer disparities. Clin Breast Cancer. 2025;25(3):193\u20137. https:\/\/doi.org\/10.1016\/j.clbc.2024.11.024.","journal-title":"Clin Breast Cancer"},{"issue":"10","key":"20637_CR29","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1245\/s10434-023-13895-5","volume":"30","author":"M Lapkus","year":"2023","unstructured":"Lapkus M, Horowitz B, Sauer C, et al. Exploring breast surgeons\u2019 attitudes on universal genetic testing: a qualitative study. Ann Surg Oncol. 2023;30(10):6108\u201316. https:\/\/doi.org\/10.1245\/s10434-023-13895-5.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"20637_CR30","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s11912-022-01340-x","volume":"24","author":"PV Bhardwaj","year":"2022","unstructured":"Bhardwaj PV, Abdou YG. Germline genetic testing in breast cancer: Systemic therapy implications. Current Oncol Rep. 2022;24(12):1791\u2013800. https:\/\/doi.org\/10.1007\/s11912-022-01340-x.","journal-title":"Current Oncol Rep"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20637-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:59:52Z","timestamp":1790881192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20637-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":30,"alternative-id":["20637"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20637-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Portions of this work were presented as a poster presentation at the American Society of Breast Surgeons conference, Seattle, Washington, May 2026.","order":2,"name":"Ethics","label":"Prior Presentation","group":{"name":"EthicsHeading","label":"Ethics"}}]}}